Symbols / PRFX Stock $2.28 -5.39% PRF Technologies Ltd.

Healthcare • Drug Manufacturers - Specialty & Generic • Israel • NCM
PRFX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Efraim Cohen-Arazi
Exch · Country NCM · Israel
Market Cap 1.93M
Enterprise Value -1.45M
Income -4.84M
Sales 17.00K
FCF (ttm) -2.00M
Book/sh 10.29
Cash/sh 4.90
Employees 6
Insider 10d
IPO Sep 01, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 0.02
Forward P/E -0.19
PEG
P/S 113.27
P/B 0.22
P/C
EV/EBITDA 0.33
EV/Sales -85.17
Quick Ratio 1.75
Current Ratio 1.78
Debt/Eq 0.23
LT Debt/Eq
EPS (ttm) -7.47
EPS next Y -12.06
EPS Growth
Revenue Growth
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2024-08-15
Earnings (prior) 2024-08-15
ROA -38.75%
ROE -90.37%
ROIC
Gross Margin 0.00%
Oper. Margin -162.00%
Profit Margin 0.00%
Shs Outstand 844.55K
Shs Float 808.62K
Insider Own 6.49%
Instit Own 2.23%
Short Float 10.02%
Short Ratio 0.06
Short Interest 84.61K
52W High 17.95
vs 52W High -87.30%
52W Low 1.80
vs 52W Low 26.88%
Beta 0.71
Impl. Vol.
Rel Volume 0.02
Avg Volume 698.15K
Volume 14.94K
Target (mean)
Tgt Median
Tgt Low
Tgt High
# Analysts
Recom None
Prev Close $2.41
Price $2.28
Change -5.39%
About

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.28
Low
High
Mean

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-10-24 down Maxim Group Buy → Hold
2024-06-26 reit Maxim Group Buy → Buy $2
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.02
0.00
0.00
0.00
Operating Revenue
0.02
0.00
0.00
0.00
Cost Of Revenue
0.07
0.00
0.00
Reconciled Cost Of Revenue
0.06
0.00
0.00
Gross Profit
-0.05
0.00
0.00
Operating Expense
5.07
-65.45%
14.67
+53.10%
9.58
+8.06%
8.87
Research And Development
1.14
-90.29%
11.71
+93.95%
6.04
+36.48%
4.42
Selling General And Administration
3.17
+6.94%
2.97
-16.37%
3.55
-20.19%
4.45
Selling And Marketing Expense
0.16
0.00
0.00
General And Administrative Expense
3.01
+1.45%
2.97
-16.37%
3.55
-20.19%
4.45
Salaries And Wages
1.12
+7.18%
1.04
-35.01%
1.61
-14.65%
1.88
Other Gand A
1.54
+1.92%
1.51
+11.65%
1.36
-18.36%
1.66
Total Expenses
5.14
-64.98%
14.67
+53.10%
9.58
+8.06%
8.87
Operating Income
-5.12
+65.09%
-14.67
-53.10%
-9.58
-8.06%
-8.87
Total Operating Income As Reported
-5.12
+65.09%
-14.67
-53.10%
-9.58
-8.06%
-8.87
EBITDA
-4.35
+70.33%
-14.66
-53.17%
-9.57
-8.08%
-8.85
Normalized EBITDA
-4.35
+70.36%
-14.66
-29.80%
-11.30
-28.48%
-8.79
Reconciled Depreciation
0.77
+4737.50%
0.02
+6.67%
0.01
+0.00%
0.01
EBIT
-5.12
+65.09%
-14.67
-53.10%
-9.58
-8.06%
-8.87
Total Unusual Items
-0.00
-133.33%
0.01
-99.65%
1.73
+2932.79%
-0.06
Total Unusual Items Excluding Goodwill
-0.00
-133.33%
0.01
-99.65%
1.73
+2932.79%
-0.06
Net Income
-5.02
+65.57%
-14.59
-56.12%
-9.34
-6.28%
-8.79
Pretax Income
-5.01
+65.61%
-14.58
-56.17%
-9.34
-6.30%
-8.78
Net Non Operating Interest Income Expense
0.11
+26.44%
0.09
+105.88%
-1.48
-1106.80%
0.15
Interest Expense Non Operating
0.00
Net Interest Income
0.11
+26.44%
0.09
+105.88%
-1.48
-1106.80%
0.15
Interest Expense
0.00
Interest Income Non Operating
0.12
+18.81%
0.10
-75.12%
0.41
+153.75%
0.16
Interest Income
0.12
+18.81%
0.10
-75.12%
0.41
+153.75%
0.16
Other Income Expense
-0.00
-133.33%
0.01
-99.65%
1.73
+2932.79%
-0.06
Gain On Sale Of Security
-0.00
-133.33%
0.01
-99.65%
1.73
+2932.79%
-0.06
Tax Provision
0.01
+0.00%
0.01
+0.00%
0.01
-11.11%
0.01
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-0.00
-133.33%
0.00
-99.65%
0.40
+2932.79%
-0.01
Net Income Including Noncontrolling Interests
-5.02
+65.57%
-14.59
-56.12%
-9.34
-6.28%
-8.79
Net Income From Continuing Operation Net Minority Interest
-5.02
+65.57%
-14.59
-56.12%
-9.34
-6.28%
-8.79
Net Income From Continuing And Discontinued Operation
-5.02
+65.57%
-14.59
-56.12%
-9.34
-6.28%
-8.79
Net Income Continuous Operations
-5.02
+65.57%
-14.59
-56.12%
-9.34
-6.28%
-8.79
Normalized Income
-5.02
+65.60%
-14.59
-36.70%
-10.67
-22.06%
-8.75
Net Income Common Stockholders
-5.02
+65.57%
-14.59
-56.12%
-9.34
-6.28%
-8.79
Diluted EPS
-105.52
+14.17%
-122.94
+61.25%
-317.30
Basic EPS
-105.52
+14.17%
-122.94
+61.25%
-317.30
Basic Average Shares
0.14
+81.90%
0.08
+174.30%
0.03
Diluted Average Shares
0.14
+81.90%
0.08
+174.30%
0.03
Diluted NI Availto Com Stockholders
-5.02
+65.57%
-14.59
-56.12%
-9.34
-6.28%
-8.79
Amortization
0.76
Amortization Of Intangibles Income Statement
0.76
Depreciation Amortization Depletion Income Statement
0.76
Depreciation And Amortization In Income Statement
0.76
Insurance And Claims
0.17
-36.12%
0.26
-33.25%
0.39
-39.66%
0.65
Rent And Landing Fees
0.18
+23.29%
0.15
-23.56%
0.19
-23.29%
0.25
Rent Expense Supplemental
0.18
+23.29%
0.15
-23.56%
0.19
-23.29%
0.25
Total Other Finance Cost
0.01
-28.57%
0.01
-99.26%
1.89
+14407.69%
0.01
Line Item Trend 2023-12-31
Total Assets
9.93
Current Assets
9.80
Cash Cash Equivalents And Short Term Investments
8.03
Cash And Cash Equivalents
8.03
Other Short Term Investments
0.00
Receivables
0.04
Other Receivables
0.04
Prepaid Assets
1.72
Restricted Cash
0.01
Other Current Assets
Total Non Current Assets
0.13
Net PPE
0.13
Gross PPE
0.13
Properties
0.00
Buildings And Improvements
0.09
Other Properties
0.04
Goodwill And Other Intangible Assets
Goodwill
Other Intangible Assets
Total Liabilities Net Minority Interest
2.69
Current Liabilities
2.41
Payables And Accrued Expenses
1.89
Payables
0.22
Accounts Payable
0.22
Current Accrued Expenses
1.67
Pensionand Other Post Retirement Benefit Plans Current
0.47
Current Debt And Capital Lease Obligation
0.06
Current Capital Lease Obligation
0.06
Total Non Current Liabilities Net Minority Interest
0.28
Long Term Debt And Capital Lease Obligation
0.03
Long Term Capital Lease Obligation
0.03
Non Current Deferred Liabilities
0.25
Non Current Deferred Taxes Liabilities
0.25
Stockholders Equity
7.24
Common Stock Equity
7.24
Capital Stock
0.00
Common Stock
0.00
Share Issued
0.01
Ordinary Shares Number
0.01
Treasury Shares Number
0.00
Additional Paid In Capital
49.10
Retained Earnings
-41.86
Minority Interest
Total Equity Gross Minority Interest
7.24
Total Capitalization
7.24
Working Capital
7.39
Invested Capital
7.24
Total Debt
0.09
Capital Lease Obligations
0.09
Net Tangible Assets
7.24
Tangible Book Value
7.24
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-3.96
+68.66%
-12.62
-88.97%
-6.68
-3.41%
-6.46
Cash Flow From Continuing Operating Activities
-3.96
+68.66%
-12.62
-88.97%
-6.68
-3.41%
-6.46
Net Income From Continuing Operations
-5.02
+65.57%
-14.59
-56.12%
-9.34
-6.28%
-8.79
Depreciation Amortization Depletion
0.77
+4737.50%
0.02
+6.67%
0.01
+0.00%
0.01
Depreciation
0.01
-6.25%
0.02
+6.67%
0.01
+0.00%
0.01
Amortization Cash Flow
0.76
Depreciation And Amortization
0.77
+4737.50%
0.02
+6.67%
0.01
+0.00%
0.01
Amortization Of Intangibles
0.76
Other Non Cash Items
-0.00
+60.00%
-0.01
-100.63%
1.58
+514.01%
0.26
Stock Based Compensation
0.45
+44.19%
0.31
-61.44%
0.80
-42.12%
1.39
Operating Gains Losses
0.00
+133.33%
-0.01
+99.56%
-1.36
Gain Loss On Investment Securities
-1.36
Net Foreign Currency Exchange Gain Loss
0.00
+133.33%
-0.01
-200.00%
-0.00
0.00
Change In Working Capital
-0.15
-109.17%
1.66
+1.78%
1.63
+142.26%
0.67
Change In Prepaid Assets
-0.02
-101.37%
1.60
+386.36%
0.33
-7.30%
0.36
Change In Payables And Accrued Expense
-0.13
-350.00%
0.05
-95.99%
1.30
+310.76%
0.32
Change In Accrued Expense
0.11
+570.83%
-0.02
-101.87%
1.29
+429.22%
0.24
Change In Payable
-0.24
-419.74%
0.08
+533.33%
0.01
-83.56%
0.07
Change In Account Payable
-0.24
-419.74%
0.08
+533.33%
0.01
-83.56%
0.07
Change In Other Current Assets
Investing Cash Flow
-0.98
-7453.85%
-0.01
-100.22%
5.99
+199.75%
-6.01
Cash Flow From Continuing Investing Activities
-0.98
-7453.85%
-0.01
-100.22%
5.99
+199.75%
-6.01
Net PPE Purchase And Sale
-0.00
+84.62%
-0.01
-44.44%
-0.01
-50.00%
-0.01
Purchase Of PPE
-0.00
+84.62%
-0.01
-44.44%
-0.01
-50.00%
-0.01
Capital Expenditure
-0.00
+84.62%
-0.01
-44.44%
-0.01
-50.00%
-0.01
Net Investment Purchase And Sale
-1.00
0.00
-100.00%
6.00
+200.00%
-6.00
Purchase Of Investment
-1.00
0.00
+100.00%
-1.00
+83.33%
-6.00
Sale Of Investment
0.00
-100.00%
7.00
Net Business Purchase And Sale
0.02
Financing Cash Flow
3.82
-56.92%
8.86
+92.01%
4.62
0.00
Cash Flow From Continuing Financing Activities
3.82
-56.92%
8.86
+92.01%
4.62
0.00
Net Issuance Payments Of Debt
Issuance Of Debt
Long Term Debt Issuance
Net Long Term Debt Issuance
Net Common Stock Issuance
4.01
-25.08%
5.35
+214.15%
1.70
0.00
Proceeds From Stock Option Exercised
0.00
-100.00%
4.75
+23.49%
3.85
0.00
Net Other Financing Charges
-0.19
+84.62%
-1.24
-32.51%
-0.93
Changes In Cash
-1.12
+70.33%
-3.77
-196.00%
3.93
+131.51%
-12.46
Effect Of Exchange Rate Changes
-0.00
-133.33%
0.01
+200.00%
0.00
0.00
Beginning Cash Position
4.27
-46.85%
8.04
+95.71%
4.11
-75.22%
16.57
End Cash Position
3.15
-26.25%
4.27
-46.85%
8.04
+95.71%
4.11
Free Cash Flow
-3.96
+68.68%
-12.63
-88.91%
-6.69
-3.45%
-6.46
Common Stock Issuance
4.01
-25.08%
5.35
+214.15%
1.70
0.00
Issuance Of Capital Stock
4.01
-25.08%
5.35
+214.15%
1.70
0.00
Sale Of Business
0.02
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category